Crowdonomics
BioLIfe Sciences Inc

Reg A+ · Equity · May 2022

ClosedReg A+Equity
via the platform · last checked Aug 16, 2026
Raised
$0 / $20M max
0% of ceiling
Investors
—
—
Estimated pre-money
$15.7M
—

Financials disclosed in this offering

FY2021 · hover for source
$0
−$783K
FY2021
RevenueNet income
Metric
FY2021
Income statement
Revenue
$0
Cost of goods sold
-$782,825
Net income
-$782,825
Balance sheet
Cash
$265,623
Accounts receivable
$340,238
Total assets
$1,610,441
Long-term debt
$310,945
Total liabilities
$1,237,864
Other
Headcount
0

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

5 amendments
  1. Mar 30, 2023
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  2. Feb 17, 2023
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  3. Feb 9, 2023
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  4. Dec 23, 2022
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  5. Nov 29, 2022
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. Form 1-A amendments state no reason; those filed before qualification are usually responses to SEC staff review.

Deal terms

Est. pre-money$15.7M
Price / share$0.275
Shares offered400,000,000

Estimated, not stated: $0.275 × 57,144,751 securities outstanding.

Offering details

Target—
Max$20,000,000
Min investment—
OpenedMay 31, 2022
Deadline—
ClosedDec 9, 2022
Days active192

Links & provenance

Source: SEC EDGAR
0001477932-22-003957
Last synced Aug 16, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.